1256 GMT - AstraZeneca's Chief Executive officer Pascal Soriot says Europe must boost investment into healthcare, as it has done with defense spending, amid what he calls a shifting world order. "Europe spends a substantially lower share of GDP on innovative medicines than the U.S. and, as a result, is falling behind in attracting R&D and manufacturing investments, putting its ability to protect the health of its own people at risk," Soriot says. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
April 23, 2025 08:57 ET (12:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.